Michael J. Brooks, President at Edesa Biotech, Inc. (EDSA), bought 3,000 shares at $1.61 ($5K) on 2022-06-16, disclosed to the SEC on 2022-06-21.
Open-market purchase of $5k EDSA by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| EDSA | BUY | 2022-05-26 | $6K | — | Filing → |
| EDSA | BUY | 2022-03-15 | $3K | — | Filing → |
| EDSA | BUY | 2022-03-11 | $3K | — | Filing → |